Import licence for medicinal products and their active ingredients
The regulatory bases for the import of pharmaceuticals and their active ingredients are very complex and are also interpreted differently by the local regulatory authorities. This makes it difficult for a non regional pharmaceutical company to find its way through the jungle of different regulations.
Grieshaber makes its logistics centres available as "permanent establishment for physical importation" and even has its own import licence for medicines in accordance with Section 72 of the German Medicines Act. Questions concerning the import of pharmaceuticals and customs clearance can be discussed with Grieshaber and case-specific processes can be defined. Grieshaber can draw on many years of expertise with the most varied customer specifications. Complex company structures due to internationally active pharmaceutical customers do not make the import process easy. Grieshaber gladly accepts the challenge of implementing the simplest possible processing in compliance with the law.
The Grieshaber quality management system is based on the guidelines of Good Manufacturing and Distribution Practice (GMP & GDP). GMP and GDP conformity (compliance) are confirmed again and again by regular customer audits and inspections by authorities.
Currently, a new annex to the GMP guideline is being discussed, which will regulate the import of medicinal products and harmonise it between EU countries. Grieshaber, as a member of EALTH (European Association for Logistics and Transport in Healthcare), discusses these new requirements at European level. When the new appendix to the GMP guideline becomes valid, Grieshaber will be able to provide practicable solutions and be available as a partner on an equal footing.
Do you have any questions on this topic? Please feel free to contact us!
Grieshaber Logistics Group AG